To slides access please click on presentation title

 

Opening 

• John Baddley: Histoplasmosis state of the art and a focus on people living with HIV care and treatment

• Flávio Queiroz Telles: Histoplasmosis in children

• Mathieu Nacher: Why are we all here? Insights in previous meetings and objectives of the present meeting.

• Tom Chiller: What has been achieved since the 2015 meeting? Realizations and trends regarding HIV-associated histoplasmosis

• Eduardo Arathoon: FUNGIRED: A model for diagnosis of opportunistic infections (OIs) in HIV for low and middle-income countries LMICs. A Comprehensive Approach. Initial Results

• Giovanni Ravasi: Progress and challenges to end AIDS in Latin America and the Caribbean: opportunities to tackle advanced HIV disease with focus on disseminated histoplasmosis Histoplasmosis 80 by 20 monitoring strategy

  

Current status of diagnosis, treatment and surveillance of histoplasmosis: analysis by regions (Chairs: Beatriz L. Gomez and Stephen Vreden)

• Dolores Niembro: North America

• Ana Belen Arauz: Central America

• Nataly Garcia: The Andes

• Marja Van Eer: The Guiana Shield

• Alessandro Pasqualotto: Brazil

• Cristina Canteros: The Southern Cone

• Glendee Reynolds: The Caribbean

​

Strategies to reach the 80 by 20 objectives: diffusion of a rapid diagnostic tool (Chairs: Cristina Canteros and Rosely Zancope)

• Beatriz L. Gomez: Diagnosis of histoplasmosis by antigen detection

• Miguel J. Martinez: High prevalence of histoplasmosis in a series of autopsies from Manaus, Brazil

• Blanca Samayoa: FungiRed implementation in Guatemala

• Alessandro Pasqualotto: Multicenter study for the detection of histoplasmosis in Brazil

• Diego H. Caceres: Implementation of a histoplasmosis RDT in Central America & Colombia

• Claudia Frola: Implementation of a histoplamosis RDT in Argentina

 

Strategies to reach the 80 by 20 objectives: improvement in effective antifungals availability in the Americas and the Caribbean (Chairs: Alessandro Pasqualotto and David Denning)

• Paul Hine: Update on the systematic review regarding HIV-associated histoplasmosis care and treatment 

• Diego Falci: Access to antifungals: situation analysis in Latin America

• David Denning: GAFFI: Resources for learning and public health

​

Regional SWOT analysis (Strength Weakness Opportunity Threat) on the access to diagnostic tests and effective antifungal therapy, and surveillance regarding HIV-associated histoplasmosis

• Giovanni Ravasi: Regional SWOT analysis (Strength Weakness Opportunity Threat) on the access to diagnostic tests and effective antifungal therapy, and surveillance regarding HIV-associated histoplasmosis

  

Histoplasmosis RDTs to whom, when and how? (Blanca Samayoa and Antoine Adenis)

• Diego H. Caceres: Systematic Review on diagnostic test for histoplasmosis

​

Meeting conclusions and perspectives for the iHAG initiative

• Giovanni Ravasi: Conclusions and main trends regarding the situation analysis by region and the SWOT analysis (focus on diagnosis, treatment access and surveillance)

• Tom Chiller: The Manaus declaration